ALK chief was weighed and found wanting
ALK’s now former CEO effectively signed his own pink slip by transforming the Danish drug group into a global player. But although the decision to let him go might have been right for the company, analysts nevertheless question the timing.
BY LOUISE WENDT JENSEN
The decision might have been the right one, but the question is if the timing was.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
ALK races against the clock on price approval
For abonnenter
ALK reaches a new Japanese milestone
For abonnenter
ALK CEO eyes higher growth rates - in 2017
For abonnenter
